Submitted by Anonymous (not verified) on 30 November 2023 - 15:21
Human medicines European public assessment report (EPAR): Inaqovi, cedazuridine,decitabine, Leukemia, Myeloid, Date of authorisation: 15/09/2023, Status: Authorised
Source: